Paper34200375
NKG2D Natural Killer Cell Receptor-A Short Description and Potential Clinical Applications.
Siemaszko J and 2 others. Cells, 2021. Cited by 68 papers, by iCite.
Cite this record
ConductScience Library. NKG2D Natural Killer Cell Receptor-A Short Description and Potential Clinical Applications. Papers, record 34200375. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34200375
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- NKG2D Natural Killer Cell Receptor-A Short Description and Potential Clinical Applications.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacterial Infections | Major topic |
| Immunity, Cellular | Major topic |
| Killer Cells, Natural | Major topic |
| NK Cell Lectin-Like Receptor Subfamily K | Major topic |
| Organ Transplantation | Major topic |
| Polymorphism, Genetic | Major topic |
| Virus Diseases | Major topic |
| Humans | |
| Ligands |
Source PubMed
References186
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23298273 | Aberrantly decreased levels of NKG2D expression in children with kawasaki disease. | Scand J Immunol | 2013 | https://conductscience.org/library/papers/23298273 | PubMed |
| 2 | 16451358 | High levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high-dose intravenous immunoglobulins. | Am J Reprod Immunol | 2006 | https://conductscience.org/library/papers/16451358 | PubMed |
| 3 | 11117911 | Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. | Lancet | 2000 | https://conductscience.org/library/papers/11117911 | PubMed |
| 4 | 22798668 | Donor NK Cells and IL-15 promoted engraftment in nonmyeloablative allogeneic bone marrow transplantation. | J Immunol | 2012 | https://conductscience.org/library/papers/22798668 | PubMed |
| 5 | 15187109 | Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients. | J Immunol | 2004 | https://conductscience.org/library/papers/15187109 | PubMed |
| 6 | 29679490 | Increased natural killer cell subsets with inhibitory cytokines and inhibitory surface receptors in patients with recurrent miscarriage and decreased or normal subsets in kidney transplant recipients late post-transplant. | Clin Exp Immunol | 2018 | https://conductscience.org/library/papers/29679490 | PubMed |
| 7 | 16397273 | Identification of the NKG2D haplotypes associated with natural cytotoxic activity of peripheral blood lymphocytes and cancer immunosurveillance. | Cancer Res | 2006 | https://conductscience.org/library/papers/16397273 | PubMed |
| 8 | 30150991 | Natural Killer Cells: Development, Maturation, and Clinical Utilization. | Front Immunol | 2018 | https://conductscience.org/library/papers/30150991 | PubMed |
| 9 | 14707119 | Bone marrow allograft rejection mediated by a novel murine NK receptor, NKG2I. | J Exp Med | 2004 | https://conductscience.org/library/papers/14707119 | PubMed |
| 10 | 16086018 | Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts. | Nat Immunol | 2005 | https://conductscience.org/library/papers/16086018 | PubMed |
| 11 | 33410220 | The low cytotoxic activity of peripheral blood NK cells may relate to unexplained recurrent miscarriage. | Am J Reprod Immunol | 2021 | https://conductscience.org/library/papers/33410220 | PubMed |
| 12 | 28805342 | Deletion of the activating NK cell receptor NKG2D accelerates rejection of cardiac allografts. | Am J Transplant | 2017 | https://conductscience.org/library/papers/28805342 | PubMed |
| 13 | 24755914 | Inflammation-related genetic variations and survival in patients with advanced non-small cell lung cancer receiving first-line chemotherapy. | Clin Pharmacol Ther | 2014 | https://conductscience.org/library/papers/24755914 | PubMed |
| 14 | 25788701 | NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT. | Blood | 2015 | https://conductscience.org/library/papers/25788701 | PubMed |
| 15 | 24769842 | Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients. | Melanoma Res | 2014 | https://conductscience.org/library/papers/24769842 | PubMed |
| 16 | 26543378 | Potential therapeutic strategy for gastric cancer peritoneal metastasis by NKG2D ligands-specific T cells. | Onco Targets Ther | 2015 | https://conductscience.org/library/papers/26543378 | PubMed |
| 17 | 19671853 | Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19671853 | PubMed |
| 18 | 25393931 | Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia. | Genes Immun | 2015 | https://conductscience.org/library/papers/25393931 | PubMed |
| 19 | 26517123 | The Effects of Intravenous Immunoglobulins in Women with Recurrent Miscarriages: A Systematic Review of Randomised Trials with Meta-Analyses and Trial Sequential Analyses Including Individual Patient Data. | PLoS One | 2015 | https://conductscience.org/library/papers/26517123 | PubMed |
| 20 | 30177859 | MICA and NKG2D variants as risk factors in spondyloarthritis: a case-control study. | Genes Immun | 2019 | https://conductscience.org/library/papers/30177859 | PubMed |
Cited by57
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42928267 | Multi-omics analysis reveals MICB promotes cerebral atherosclerosis through FTMT suppression in NK and plasma cells. | Clin Epigenetics | 2026 | https://conductscience.org/library/papers/42928267 | PubMed |
| 42922552 | Differentiation-coupled intron retention reveals a candidate NKG2D-TR-like isoform at the murine Klrk1 locus. | bioRxiv | 2026 | https://conductscience.org/library/papers/42922552 | PubMed |
| 42738255 | Donor NKG2A/NKG2C Immunophenotype Influences the GMP-Compliant Manufacturing Potential of NK Cells for Adoptive Immunotherapy. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42738255 | PubMed |
| 42548496 | MICA-129Met/Val as a therapeutic compass in idiopathic pulmonary fibrosis: prognosis and antifibrotic benefit. | Front Immunol | 2026 | https://conductscience.org/library/papers/42548496 | PubMed |
| 42194161 | Longitudinal Dynamics of NK-Cell Regulatory Signaling and IVIG Response in Kawasaki Disease. | Children (Basel) | 2026 | https://conductscience.org/library/papers/42194161 | PubMed |
| 42185849 | Targeting the NKG2D axis in head and neck squamous cell carcinoma: from molecular insights to clinical applications. | Cancer Cell Int | 2026 | https://conductscience.org/library/papers/42185849 | PubMed |
| 42064075 | TLR2 activation potentiates P-glycoprotein-mediated methotrexate efflux and enhances cytotoxicity of human NK cells against acute lymphoblastic leukemia. | Front Immunol | 2026 | https://conductscience.org/library/papers/42064075 | PubMed |
| 41965340 | Allogeneic CD19 CAR T cells armed with an anti-rejection CD70 CAR overcome antigen escape and evade alloimmune responses. | Nat Commun | 2026 | https://conductscience.org/library/papers/41965340 | PubMed |
| 41929521 | Natural killer cell dysfunction in glioma: from immune evasion to immunotherapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/41929521 | PubMed |
| 41756289 | NKG2D CAR-T cells for solid tumor immunotherapy: advances, challenges, and future directions. | Front Immunol | 2026 | https://conductscience.org/library/papers/41756289 | PubMed |
| 41490616 | [Research progress of the ULBP-NKG2D axis in autoimmune diseases]. | Zhejiang Da Xue Xue Bao Yi Xue Ban | 2026 | https://conductscience.org/library/papers/41490616 | PubMed |
| 41488635 | Lipocalin-2 modulates recipients alloimmune responses to the murine kidney transplants. | Front Immunol | 2025 | https://conductscience.org/library/papers/41488635 | PubMed |
| 41446651 | "Live" cell shipment-a forward-looking transport option for cryo-sensitive cell-based therapies. | Front Bioeng Biotechnol | 2025 | https://conductscience.org/library/papers/41446651 | PubMed |
| 41196398 | CAR-T cells immunotherapy in the treatment of glioblastoma. | Cancer Immunol Immunother | 2025 | https://conductscience.org/library/papers/41196398 | PubMed |
| 41185627 | Uncovering Cellular Interactome Drivers of Immune Checkpoint Inhibitor Response in Advanced Melanoma Patients. | Cell Mol Bioeng | 2025 | https://conductscience.org/library/papers/41185627 | PubMed |
| 41153412 | Genetic Variability in NKG2 Receptors and Their Ligands: Associations with SARS-CoV-2 Infection and COVID-19 Severity. | Genes (Basel) | 2025 | https://conductscience.org/library/papers/41153412 | PubMed |
| 41096812 | Translational Insights into NK Immunophenotyping: Comparative Surface Marker Analysis and Circulating Immune Cell Profiling in Cancer Immunotherapy. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41096812 | PubMed |
| 40982140 | Novel and recurrent mutations in exon 8 of natural killer group 2D (NKG2D) gene among chronic myeloid leukemia patients and their potential role in pathogenesis. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/40982140 | PubMed |
| 40948757 | Enhancing natural killer cell anti-tumour activity through macrophage manipulation. | Front Immunol | 2025 | https://conductscience.org/library/papers/40948757 | PubMed |
| 40862731 | Donor Variability and Seeding Density Shape NK-Cell Proliferation and Surface Receptor Expression: Insights from an Integrated Phenotypic and Genetic Analysis. | Cells | 2025 | https://conductscience.org/library/papers/40862731 | PubMed |
Genes78
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34200375
GET https://conductscience.org/api/papers/v1/34200375/references?page=2